Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capromorelin in frail older adults
NCT00527046Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Dec 1999
- Primary completion
- Oct 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capromorelin in frailty syndrome, sponsored by Pfizer. Started Dec 1999; status: terminated.
02
Drugs
capromorelin
03
Conditions
frailty syndrome
Beyond the preview
Go deeper on NCT00527046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00527046.